DData Read More Viking Tops Novo As Obesity Pill Brawl Continues, But Shares DiveNovember 4, 2024 Viking Therapeutics’ (VKTX) highly anticipated weight-loss pill topped Wall Street’s expectations — and a rival pill from Novo…